What is the official website of Yller Biomateriais S/A ?

The official website of Yller Biomateriais S/A is http://www.yller.com.br.

What is Yller Biomateriais S/A's cybersecurity risk score?

Yller Biomateriais S/A has an AI-generated cybersecurity risk score of 758 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Yller Biomateriais S/A experienced?

According to Rankiteo, Yller Biomateriais S/A currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Yller Biomateriais S/A been affected by any supply chain cyber incidents ?

According to Rankiteo, Yller Biomateriais S/A has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Yller Biomateriais S/A have SOC 2 Type 1 certification ?

According to Rankiteo, Yller Biomateriais S/A is not certified under SOC 2 Type 1.

Does Yller Biomateriais S/A have SOC 2 Type 2 certification ?

According to Rankiteo, Yller Biomateriais S/A does not hold a SOC 2 Type 2 certification.

Does Yller Biomateriais S/A comply with GDPR ?

According to Rankiteo, Yller Biomateriais S/A is not listed as GDPR compliant.

Does Yller Biomateriais S/A have PCI DSS certification ?

According to Rankiteo, Yller Biomateriais S/A does not currently maintain PCI DSS compliance.

Does Yller Biomateriais S/A comply with HIPAA ?

According to Rankiteo, Yller Biomateriais S/A is not compliant with HIPAA regulations.

Does Yller Biomateriais S/A have ISO 27001 certification ?

According to Rankiteo,Yller Biomateriais S/A is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Yller Biomateriais S/A operate in ?

Yller Biomateriais S/A operates primarily in the Medical Equipment Manufacturing industry.

How many employees does Yller Biomateriais S/A have ?

Yller Biomateriais S/A employs approximately 44 people worldwide.

Does Yller Biomateriais S/A own any subsidiaries ?

Yller Biomateriais S/A presently has no subsidiaries across any sectors.

How many LinkedIn followers does Yller Biomateriais S/A have ?

Yller Biomateriais S/A's official LinkedIn profile has approximately 3,501 followers.

What is the NAICS classification code for Yller Biomateriais S/A ?

Yller Biomateriais S/A is classified under the NAICS code 3391, which corresponds to Medical Equipment and Supplies Manufacturing.

Does Yller Biomateriais S/A have a Crunchbase profile ?

Yes, Yller Biomateriais S/A has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/yller.

Does Yller Biomateriais S/A have a LinkedIn profile ?

Yes, Yller Biomateriais S/A maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/yller-biomateriais-ltda.

How many cybersecurity incidents has Yller Biomateriais S/A experienced ?

As of September 3, 2026, Rankiteo reports that Yller Biomateriais S/A has not experienced any cybersecurity incidents.

How many peer or competitor companies does Yller Biomateriais S/A have ?

Yller Biomateriais S/A has an estimated 5,946 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

YBS

Boost Score +25 with badge (5 left)

758

/1000

Fair

783

/1000

Fair

Yller Biomateriais S/A Vendor Cyber Rating & Cyber Score

yller.com.br

cb in

Add Your Compliance Badge

An industry with an innovative spirit in full growth! Yller is a dental materials industry, a closed-end corporation, which was created in the year 2012 and which has significant national recognition due to the expertise of the founding partners in the area of material development. Yller invests expressively its capital in research and development, propelling factor of the company, being the main reason of differentiation of products and continuous launch of innovations. www.yller.com.br www.yllerdigital.com.br

YBS A.I CyberSecurity Scoring

Scoring History

YBS

Yller Biomateriais S/A CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

YBS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for YBS

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Yller Biomateriais S/A in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Yller Biomateriais S/A in 2026.

Incident Types YBS vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Yller Biomateriais S/A in 2026.

Incident History - YBS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Yller Biomateriais S/A Subsidiaries

YBS

Medical Equipment Manufacturing

Website: http://www.yller.com.br

Company Size: 44

Straumann GroupMedical Equipment Manufacturing

NeodentMedical Equipment Manufacturing

Neodent ItaliaFabbricazione di apparecchiature medicali

StraumannMedical Equipment Manufacturing

ClearCorrectMedical Equipment Manufacturing

DR SMILEMedical Equipment Manufacturing

DR SMILE IberiaFabricación de equipo médico

ITI - International Team for ImplantologyEducation

ITI India - International Team for ImplantologyEducation

Dental WingsMedical Equipment Manufacturing

Dental Wings Digital Dentistry SolutionsMedical Equipment Manufacturing

AnthogyrMedical Equipment Manufacturing

MedentikaMedical Equipment Manufacturing

Straumann Digital Planning Services (Pvt.) Ltd.Medical Practices

InstradentMedical Equipment Manufacturing

Zendura DentalPlastics Manufacturing

Abutment Direct Inc.Medical Device

Valoc AGMedical Equipment Manufacturing

Neodent UKMedical Device

Women Implantology NetworkMedical Equipment Manufacturing

youToothMedical Equipment Manufacturing

T-PLUS Implant Tech. Co., Ltd.Medical Device

Medentika UKMedical Equipment Manufacturing

ClearCorrect UKMedical Equipment Manufacturing

Nuvo GlobalFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Zinedent İmplantWellness and Fitness Services

Loading…

Yller Biomateriais S/A Similar Companies

Align Technology

aligntech.com

We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com

Beckman Coulter Diagnostics

beckmancoulter.com

A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.

Edwards Lifesciences

edwards.com

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.

Stryker

stryker.com

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

Boston Scientific

bostonscientific.com

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.

Baxter International Inc.

baxter.com

For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.

Henry Schein

cb henryschein.com

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

Olympus Corporation

olympus-global.com

Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.

Medline

medline.com

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Loading…

NEWS

Yller Biomateriais S/A CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-84857

SUMMARY

A flaw has been found in sigoden aichat up to 0.30.4. This affects an unknown function of the file src/serve.rs of the component API Endpoint. This manipulation causes uncontrolled memory allocation. The attack can be initiated remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-02

Updated

Date2026-09-02

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:N/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-84856

SUMMARY

A vulnerability was detected in rowboatlabs rowboat up to 0.9.1. The impacted element is the function request.text/req.json of the file apps/rowboat/app/api/composio/webhook/route.ts of the component Composio Webhook Endpoint. The manipulation results in denial of service. It is possible to launch the attack remotely. The exploit is now public and may be used. Upgrading to version 0.9.2 is sufficient to resolve this issue. Upgrading the affected component is recommended. The legacy Next.js app was deleted at 0.9.2 rather than patched, leaving no security control behind.

Published

Date2026-09-02

Updated

Date2026-09-02

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:N/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-84852

SUMMARY

A security vulnerability has been detected in Reader Tools PDF Reader App 98.8 on Android. The affected element is the function ActSplashNew.handleDeeplink of the component File Handler. The manipulation of the argument _display_name leads to path traversal. An attack has to be approached locally. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-02

Updated

Date2026-09-02

RISK INFORMATION (Score: 4.4)

cvss2

Base Score: 3.2

Complexity: LOW

AV:L/AC:L/Au:S/C:N/I:P/A:P

cvss3

Base Score: 4.4

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

1.8

REFERENCES

CVE-2026-84452

SUMMARY

Windows ML CLI is a command line tool for building portable, performant, and high-quality AI models for Windows ML. Prior to 0.4.0, the src/winml/modelkit/serve/cli_api.py component exposes WinML CLI commands through a localhost HTTP API without authentication and configures the allow_origins setting as a wildcard in both src/winml/modelkit/serve/cli_api.py and src/winml/modelkit/serve/app.py. A malicious website loaded by a user can send cross-origin requests to /v1/cli/build or /v1/cli/config and set the trust_remote_code parameter to true, which is converted to the --trust-remote-code command-line flag without validation. This reaches AutoConfig.from_pretrained with trust_remote_code=True in src/winml/modelkit/loader/_autoconfig.py and imports Python code from an attacker-controlled model repository, resulting in arbitrary code execution as the server user. This issue is fixed in version 0.4.0.

Published

Date2026-09-02

Updated

Date2026-09-02

RISK INFORMATION (Score: )

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-84292

SUMMARY

fast-uri serializes the port component of a URI without validating it. When recomposing the authority, the userinfo and host components are escaped but the port is concatenated verbatim, so a port value that is not a sequence of digits can inject authority delimiters, demoting the intended host to userinfo and pointing the authority at an attacker-controlled host. Both fast-uri and Node's URL read the result back as the attacker's host with no error, so re-validating the built URI does not catch it. This affects applications that build URIs from parts and assign untrusted data to the port component through the serialize, normalize, or equal functions in their object forms. The issue affects fast-uri versions before 2.4.6, from 3.0.0 before 3.1.7, and from 4.0.0 before 4.1.4. It is fixed in 2.4.6, 3.1.7, and 4.1.4, where recomposeAuthority rejects any port that is not a digit sequence per RFC 3986.

Published

Date2026-09-02

Updated

Date2026-09-02

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…